VISEN Pharmaceuticals (2561.HK) Earnings Analysis
VISEN Pharmaceuticals (2561.HK) next reports earnings on 2026-08-27. Trailing P/E -6.81.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2561.HK next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2561.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-27 | -1.29304 HKD | n/a | n/a | n/a |
2561.HK valuation and analyst view
| Trailing P/E | -6.81 |
|---|---|
| Trailing EPS | -2.36217 HKD |
| Price / book | 2.34 |
| Dividend yield | 0.00% |
| Market cap | 2.06B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is VISEN Pharmaceuticals (2561.HK)'s next earnings date?
VISEN Pharmaceuticals is next scheduled to report on 2026-08-27.
Did 2561.HK beat earnings last quarter?
Consensus estimate data was not available for 2561.HK's 2025-08-27 report.
What is 2561.HK's current P/E ratio and EPS?
2561.HK trades at a trailing P/E of -6.81 on trailing EPS of -2.3621651135163684 HKD.
What do analysts rate 2561.HK?
2561.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.